Preop Laxatives in Robotic Urologic Surgery

Launched by CHAD R. TRACY · Mar 22, 2023

Keywords

ClinConnect Summary

This clinical trial is studying whether taking a specific type of laxative called polyethylene glycol (PEG, also known as MiraLAX) before surgery can help patients recover better from robotic urologic procedures, such as surgeries for prostate or kidney cancer. Many patients experience issues like nausea, bloating, and difficulty having bowel movements after surgery, which can delay their recovery. In this trial, some patients will take the laxative for three days before their surgery, while others will not. All participants will follow the same plan for bowel care after surgery, and they will keep track of their symptoms and when they have their first bowel movement.

To be eligible for this study, patients need to be at least 30 years old and scheduled for certain robotic-assisted surgeries. They cannot have certain health conditions or take laxatives regularly. Participants will be asked to complete questionnaires and keep a diary about their recovery, which will help researchers understand if taking the laxative beforehand makes a difference in their recovery experience. This study is currently looking for volunteers and aims to improve the overall recovery process for patients undergoing these types of surgeries.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • -Patients 30 years or older undergoing robotic-assisted laparoscopic radical prostatectomy, transperitoneal radical nephrectomy, or transperitoneal partial nephrectomy
• Exclusion criteria:
• • Patients under 30 years old
• • Patients with a contraindication to receiving polyethylene glycol or other forms of laxatives
• • People who regularly take Miralax
• • Patients undergoing retroperitoneal radical or partial nephrectomy
• • Patients with severe ulcerative colitis or Crohn's disease
• • Patients with intestinal diversions (colostomy, ileostomy)
• • Patients with prior abdominal or pelvic radiation
• • Patients who will not follow up with UIHC postoperatively
• • Patients who are incarcerated